Results 181 to 190 of about 2,347 (191)

Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?

Cancer Chemotherapy and Pharmacology, 2010
Ahmet Bilici, Bala Basak Oven Ustaalioglu, Serif Ercan   +2 more
exaly  

M65 On-Site Generation of Hypochlorite, First Edition

2015
openaire   +1 more source

Can circulating M30 and M65 levels be beneficial markers in the diagnosis and management of patients with complete hydatidiform mole?

Wiener Klinische Wochenschrift, 2015
Adnan Incebiyik, Mehmet Vural, Håkan Camuzcuoglu   +2 more
exaly  

The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer

Medical Oncology, 2013
Bala Basak Oven Ustaalioglu, Ahmet Bilici, Serif Ercan   +2 more
exaly  

Soluble intracellular adhesion molecule, M30 and M65 as serum markers of disease activity and prognosis in cholestatic liver diseases

Hepatology Research, 2014
Gerald Denk, Simon Hohenester, Ralf Wimmer   +2 more
exaly  

Cell death biomarker M65 is a useful indicator of liver inflammation and fibrosis in chronic hepatitis B

Medicine (United States), 2017
Xinhuan Wei, Hongshan Wei, Zhongjie Hu   +2 more
exaly  

Russland storniert LMV-M65 : zurück zum eigenen Tigr-M

2015
openaire   +1 more source

M65. THE GENETIC ARCHITECTURE OF BRAIN VOLUMES IN FEMALES AND MALES: INSIGHTS FROM A MULTIVARIATE APPROACH

European Neuropsychopharmacology
Edith Breton, Gloria Matte Bon, Ole Andreassen, Tobias Kaufmann   +3 more
openaire   +1 more source

Evaluation of M65 Concrete Mix Design: A Comparative Study of IS Code Compliance and Strength Attainment

Bibek Thapa, Prashna Yagoju, Nischal Thapaliya, Rejina Karki   +3 more
openaire   +1 more source

Cell death-based pharmacodynamic biomarkers (M30 and M65): the pros and cons

2015
openaire   +1 more source